Grant: Master's Award: Canada Graduate Scholarships
University of Calgary
$27,000.00
Short-term Intravenous Fluids for Prevention of Post-ERCP Pancreatitis (the STRIPE Study)
FY 2024-25
Summary
The Short-term Intravenous Fluids for Prevention of Post-ERCP Pancreatitis (STRIPE) study investigates the effectiveness of peri-procedural intravenous fluids in reducing post-ERCP pancreatitis (PEP), a significant complication associated with ERCP procedures. Post-ERCP pancreatitis leads to patient morbidity, prolonged hospital stays, and substantial healthcare costs, highlighting the urgent need for effective preventative strategies. Although rectal NSAIDs, pancreatic duct stenting, and aggressive post-procedural hydration have shown potential in mitigating PEP risk, each approach has limitations, including underutilization, cost, technical complexity, and impracticality in outpatient settings.The STRIPE study aims to assess the efficacy of various short-term IV fluid regimens in preventing PEP by using serum amylase levels at 24 hours post-procedure as an intermediate biomarker for PEP. Patients undergoing ERCP will be randomized into one of five study arms, each representing a different volume of Ringer lactate solution administered peri-procedurally. This design builds on prior research demonstrating that elevated amylase levels correlate with increased PEP risk and can serve as a surrogate endpoint, allowing for a more feasible trial size.Conducted at the Peter Lougheed Center, this blinded, randomized controlled trial leverages existing endoscopy infrastructure and will use real-time data collection. Outcomes include primary (amylase levels) and secondary measures, such as 30-day adverse events, unplanned healthcare encounters, and hospitalizations. Results from the STRIPE study aim to guide the optimal use of IV fluids in ERCP, potentially improving patient outcomes, reducing costs, and establishing an evidence-based approach for PEP prevention.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
530243
Name
Guo Howard
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Short-term Intravenous Fluids for Prevention of Post-ERCP Pancreatitis (the STRIPE Study)
Programtype2
Studentship Programs
Orgnameinp2
University of Calgary
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Amylase; Endoscopic Retrograde Cholangiopancreatography; Intravenous Fluids; Pancreatitis
Abstract
The Short-term Intravenous Fluids for Prevention of Post-ERCP Pancreatitis (STRIPE) study investigates the effectiveness of peri-procedural intravenous fluids in reducing post-ERCP pancreatitis (PEP), a significant complication associated with ERCP procedures. Post-ERCP pancreatitis leads to patient morbidity, prolonged hospital stays, and substantial healthcare costs, highlighting the urgent need for effective preventative strategies. Although rectal NSAIDs, pancreatic duct stenting, and aggressive post-procedural hydration have shown potential in mitigating PEP risk, each approach has limitations, including underutilization, cost, technical complexity, and impracticality in outpatient settings.The STRIPE study aims to assess the efficacy of various short-term IV fluid regimens in preventing PEP by using serum amylase levels at 24 hours post-procedure as an intermediate biomarker for PEP. Patients undergoing ERCP will be randomized into one of five study arms, each representing a different volume of Ringer lactate solution administered peri-procedurally. This design builds on prior research demonstrating that elevated amylase levels correlate with increased PEP risk and can serve as a surrogate endpoint, allowing for a more feasible trial size.Conducted at the Peter Lougheed Center, this blinded, randomized controlled trial leverages existing endoscopy infrastructure and will use real-time data collection. Outcomes include primary (amylase levels) and secondary measures, such as 30-day adverse events, unplanned healthcare encounters, and hospitalizations. Results from the STRIPE study aim to guide the optimal use of IV fluids in ERCP, potentially improving patient outcomes, reducing costs, and establishing an evidence-based approach for PEP prevention.
Competitiondate
202412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Guo, Howard
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~